Sesen Bio CARISMA Merger 2023 Shareholder Presentation

Investor presentation detailing Sesen Bio's proposed merger with CARISMA Therapeutics and concurrent financing arrangements. The presentation outlines the combined company's strategy, product pipeline advancement, expected ownership structure, and contingent value rights for shareholders.